These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 11408217

  • 1. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG, Saunders DG, Hoban DJ, Karlowsky JA.
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC, Sobel JD, Nailor MD.
    Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P.
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [Abstract] [Full Text] [Related]

  • 5. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H, Aurbach U, Stefanik D, Cornely O.
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D, Watelle M, Van der Flaes M, Nolard N.
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [Abstract] [Full Text] [Related]

  • 7. Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans.
    Mínguez F, Lima JE, García MT, Prieto J.
    Chemotherapy; 1996 Jun; 42(4):273-9. PubMed ID: 8804795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Colorimetric broth microdilution for antifungal susceptibility testing].
    Yamane N, Tosaka M, Okazawa Y.
    Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
    [Abstract] [Full Text] [Related]

  • 14. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D, Díaz MC, Silva V.
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [Abstract] [Full Text] [Related]

  • 15. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
    Moore CB, Oakley KL, Denning DW.
    Clin Microbiol Infect; 2001 Jan; 7(1):11-6. PubMed ID: 11284937
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.